Why Shares of Editas Medicine Dropped 15.5% in November The Motley Fool Nawigacja wpisu Keeping Things Clean with the DiRTE Lab – Duke University School of Medicine Study Shows Promise of New Anti-KRAS Drug for Pancreatic Cancer – Penn Medicine
